צמיחת הכנסות מרבעון לרבעון: Predictive Oncology Inc (POAI)

Stable revenues from long-term B2B contracts at Predictive Oncology (POAI) are supplemented by the automation of equipment calibration via robots. The quarterly revenue growth rate visualizes this synergy, where -99.60 serves as the final level marker. However, global trade barriers and export controls on AI data may slow the company's international expansion within the oncology diagnostics sector.
Predictive Oncology (POAI) - פילוחי מדדים ודוחות פיננסיים

This indicator captures the percentage deviation of current revenue from the previous quarter's figures, revealing the business scaling rates and the operational resilience of the company. For Predictive Oncology (POAI), the quarterly revenue growth trend confirms the effectiveness of AI solution implementation, where long-term agreements with pharma behemoths are transforming one-off sales into a stable recurring cash flow.